TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,928,656 | -11.6% | 1,796,773 | -10.1% | 2.23% | -25.4% |
| Q2 2023 | $36,128,850 | +304.0% | 1,999,383 | +282.8% | 3.00% | +250.3% |
| Q3 2022 | $8,942,000 | +14.6% | 522,329 | -2.3% | 0.86% | +13.4% |
| Q2 2022 | $7,804,000 | -13.2% | 534,524 | 0.0% | 0.75% | -12.8% |
| Q1 2022 | $8,991,000 | -22.3% | 534,524 | +3.9% | 0.86% | -17.6% |
| Q4 2021 | $11,572,000 | +4.4% | 514,289 | 0.0% | 1.05% | +100.0% |
| Q3 2021 | $11,083,000 | -25.6% | 514,289 | 0.0% | 0.52% | -32.5% |
| Q2 2021 | $14,904,000 | – | 514,289 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |